Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Mesoblast announces publication of results on remestemcel-L » 08:08
10/18/21
10/18
08:08
10/18/21
08:08
MESO

Mesoblast

$5.73 /

-0.11 (-1.88%)

Mesoblast announced that…

Mesoblast announced that results published in the latest issue of the peer-reviewed journal Bone Marrow Transplantation showed that children with steroid-refractory acute graft versus host disease and biomarkers predictive for highest mortality had 64% survival when treated with remestemcel-L compared with only 10% survival when treated with other available therapies, including ruxolitinib or other biologics. These data provide further support for the proposed anti-inflammatory mechanism of action of remestemcel-L and its immunomodulatory activity in patients with SR-aGVHD, resulting in improved survival outcomes. At its upcoming scheduled meeting with FDA's Office of Tissue and Advanced Therapies, Mesoblast will address the appropriateness of potency assays related to remestemcel-L's proposed anti-inflammatory mechanism of action as well as the outstanding chemistry, manufacturing and controls items which could support a resubmission of the current Biologics License Application for remestemcel-L in the treatment of SR-aGVHD in children. The study compared outcomes in 25 children from Mesoblast's Phase 3 trial of remestemcel-L in SR-aGVHD with 27 closely matched children from the Mount Sinai Acute GVHD International Consortium who participated in a prospective natural history study and were matched for the Phase 3 trial entry criteria. The objective of the study was to evaluate whether outcomes differed according to treatment with remestemcel-L vs other therapies in children at highest risk of death, namely those with baseline MAGIC Algorithm Probability biomarker levels greater than or equal to0.291, a level predictive of very high mortality and poor responses to therapy in SR-aGVHD. MAP combines the serum concentrations of two biomarkers, Reg3alpha and ST2, into a single value that predicts long-term outcomes and significant GI tract damage. MAP levels greater than or equal to0.291 were present in 48% of remestemcel-L treated children and 37% of the MAGIC cohort. Treatment with remestemcel-L resulted in 67% Day 28 Overall Response and 64% Day 180 overall survival compared with 10% Day 28 Overall Response and 10% Day 180 survival in the MAGIC cohort when treated with various biologics, including ruxolitinib. These results extend previous observations showing that children who achieved clinically meaningful responses and survival after treatment with remestemcel-L had significant reductions in the ST2 biomarker of inflammation, consistent with healing of the GI tract.

ShowHide Related Items >><<
MESO Mesoblast
$5.73 /

-0.11 (-1.88%)

MESO Mesoblast
$5.73 /

-0.11 (-1.88%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
MESO Mesoblast
$5.73 /

-0.11 (-1.88%)

MESO Mesoblast
$5.73 /

-0.11 (-1.88%)

Hot Stocks
Mesoblast's phase 3 trial data of rexlemestrocel-L selected for AHA presentation » 21:01
10/06/21
10/06
21:01
10/06/21
21:01
MESO

Mesoblast

$5.56 /

-0.165 (-2.88%)

Mesoblast "announced…

Mesoblast "announced that results from the randomized, controlled Phase 3 trial of rexlemestrocel-L in 565 patients with New York Heart Association class II and class III chronic heart failure with low ejection fraction have been selected through peer review as a late breaking presentation at the American Heart Association annual meeting occurring November 13th- 15th. The featured session is titled 'Building on the Foundations of Treatment: Advances in Heart Failure Therapy'. The session will also feature late breaking results from two additional heart failure trials with SGLT-2 Inhibitors."

ShowHide Related Items >><<
MESO Mesoblast
$5.56 /

-0.165 (-2.88%)

MESO Mesoblast
$5.56 /

-0.165 (-2.88%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
MESO Mesoblast
$5.56 /

-0.165 (-2.88%)

MESO Mesoblast
$5.56 /

-0.165 (-2.88%)

Over a month ago
Conference/Events
Mesoblast management to meet virtually with Maxim » 04:55
09/23/21
09/23
04:55
09/23/21
04:55
MESO

Mesoblast

$6.03 /

+0.03 (+0.50%)

Virtual Meeting to be…

Virtual Meeting to be held on September 21-23 hosted by Maxim.

ShowHide Related Items >><<
MESO Mesoblast
$6.03 /

+0.03 (+0.50%)

MESO Mesoblast
$6.03 /

+0.03 (+0.50%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
MESO Mesoblast
$6.03 /

+0.03 (+0.50%)

MESO Mesoblast
$6.03 /

+0.03 (+0.50%)

Conference/Events
Mesoblast management to meet virtually with Maxim » 04:55
09/22/21
09/22
04:55
09/22/21
04:55
MESO

Mesoblast

$5.99 /

+0.13 (+2.22%)

Virtual Meeting to be…

Virtual Meeting to be held on September 21-23 hosted by Maxim.

ShowHide Related Items >><<
MESO Mesoblast
$5.99 /

+0.13 (+2.22%)

MESO Mesoblast
$5.99 /

+0.13 (+2.22%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
MESO Mesoblast
$5.99 /

+0.13 (+2.22%)

MESO Mesoblast
$5.99 /

+0.13 (+2.22%)

Conference/Events
Mesoblast management to meet virtually with Maxim » 12:28
09/21/21
09/21
12:28
09/21/21
12:28
MESO

Mesoblast

$6.04 /

+0.18 (+3.07%)

Virtual Meeting to be…

Virtual Meeting to be held on September 21-23 hosted by Maxim.

ShowHide Related Items >><<
MESO Mesoblast
$6.04 /

+0.18 (+3.07%)

MESO Mesoblast
$6.04 /

+0.18 (+3.07%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
MESO Mesoblast
$6.04 /

+0.18 (+3.07%)

MESO Mesoblast
$6.04 /

+0.18 (+3.07%)

On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:16
08/31/21
08/31
16:16
08/31/21
16:16
CNI

Canadian National

$117.66 /

+8.01 (+7.31%)

, CP

Canadian Pacific

$68.75 /

-3.3 (-4.58%)

, KSU

Kansas City Southern

$280.74 /

-12.88 (-4.39%)

, ZM

Zoom Video

$289.48 /

-58.31 (-16.77%)

, YNDX

Yandex

$76.91 /

+3.78 (+5.17%)

, UBER

Uber

$39.15 /

-0.4 (-1.01%)

, JNJ

Johnson & Johnson

$173.11 /

-0.56 (-0.32%)

, VG

Vonage

$14.11 /

+0.61 (+4.52%)

, SPCE

Virgin Galactic

$27.11 /

+2.24 (+9.01%)

, FNKO

Funko

$19.92 /

+1.3 (+6.98%)

, APPS

Digital Turbine

$58.53 /

+7.28 (+14.20%)

, MESO

Mesoblast

$6.53 /

-0.765 (-10.49%)

, TXT

Textron

$72.68 /

+0.73 (+1.01%)

, AAPL

Apple

$151.84 /

-1.27 (-0.83%)

, TSM

TSMC

$119.02 /

+0.01 (+0.01%)

, GOOG

Alphabet

$2,910.98 /

+3.825 (+0.13%)

, GOOGL

Alphabet Class A

$2,893.93 /

+1.5 (+0.05%)

, AMZN

Amazon.com

$3,471.36 /

+49.99 (+1.46%)

, WFC

Wells Fargo

$45.70 /

-2.71 (-5.60%)

, ACIU

AC Immune

$8.09 /

+1.075 (+15.32%)

, SONN

Sonnet BioTherapeutics

/

+

, EGRX

Eagle Pharmaceuticals

$53.53 /

+5.62 (+11.73%)

, ENDP

Endo

$2.28 /

-0.03 (-1.30%)

, GSAT

Globalstar

$1.98 /

-0.36 (-15.38%)

, IRDM

Iridium

$44.54 /

-2.36 (-5.03%)

, SOL

ReneSola

$7.01 /

-0.09 (-1.27%)

, AMWD

American Woodmark

$70.50 /

-10.41 (-12.87%)

, DBI

Designer Brands

$14.52 /

-1.29 (-8.16%)

, DXLG

Destination XL

$5.99 /

+0.75 (+14.31%)

, NTES

NetEase

$97.47 /

+7.87 (+8.78%)

, CHS

Chico's

$5.17 /

-0.685 (-11.71%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

YNDX Yandex
$76.91 /

+3.78 (+5.17%)

WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

VG Vonage
$14.11 /

+0.61 (+4.52%)

UBER Uber
$39.15 /

-0.4 (-1.01%)

TXT Textron
$72.68 /

+0.73 (+1.01%)

TSM TSMC
$119.02 /

+0.01 (+0.01%)

SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

SONN Sonnet BioTherapeutics
/

+

SOL ReneSola
$7.01 /

-0.09 (-1.27%)

NTES NetEase
$97.47 /

+7.87 (+8.78%)

MESO Mesoblast
$6.53 /

-0.765 (-10.49%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

IRDM Iridium
$44.54 /

-2.36 (-5.03%)

GSAT Globalstar
$1.98 /

-0.36 (-15.38%)

GOOGL Alphabet Class A
$2,893.93 /

+1.5 (+0.05%)

GOOG Alphabet
$2,910.98 /

+3.825 (+0.13%)

FNKO Funko
$19.92 /

+1.3 (+6.98%)

ENDP Endo
$2.28 /

-0.03 (-1.30%)

EGRX Eagle Pharmaceuticals
$53.53 /

+5.62 (+11.73%)

DXLG Destination XL
$5.99 /

+0.75 (+14.31%)

DBI Designer Brands
$14.52 /

-1.29 (-8.16%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

CHS Chico's
$5.17 /

-0.685 (-11.71%)

APPS Digital Turbine
$58.53 /

+7.28 (+14.20%)

AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

AMWD American Woodmark
$70.50 /

-10.41 (-12.87%)

ACIU AC Immune
$8.09 /

+1.075 (+15.32%)

AAPL Apple
$151.84 /

-1.27 (-0.83%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

09/01/21 Loop Capital
Canadian National, Kansas City Southern cut to Hold at Loop Capital
09/01/21 Citi
Citi upgrades Canadian National to Buy on operating ratio refocus
09/01/21 Citi
Canadian National upgraded to Buy from Neutral at Citi
09/01/21 Loop Capital
Canadian National downgraded to Hold from Buy at Loop Capital
CP Canadian Pacific
$68.75 /

-3.3 (-4.58%)

08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
07/29/21 CIBC
Canadian Pacific price target raised to C$106 from C$105 at CIBC
KSU Kansas City Southern
$280.74 /

-12.88 (-4.39%)

09/01/21 Loop Capital
Kansas City Southern downgraded to Hold from Buy at Loop Capital
ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

08/31/21 KeyBanc
Zoom Video price target lowered to $398 from $428 at KeyBanc
08/31/21 Stifel
Zoom Video price target lowered to $350 from $450 at Stifel
08/31/21 Deutsche Bank
Zoom Video price target lowered to $350 from $375 at Deutsche Bank
08/31/21 BofA
Zoom Video price target lowered to $385 from $480 at BofA
YNDX Yandex
$76.91 /

+3.78 (+5.17%)

04/14/21 VTB Capital
Yandex pullback on FAS probe a buying opportunity, says VTB Capital
04/14/21 VTB Capital
Yandex named long idea after 'excessive' selloff at VTB Capital
04/06/21 New Street
New Street starts Yandex at Buy with focus on food, grocery
04/06/21 New Street
Yandex initiated with a Buy at New Street
UBER Uber
$39.15 /

-0.4 (-1.01%)

08/23/21 JPMorgan
Court ruling brings near-term uncertainty to Uber and Lyft, says JPMorgan
08/23/21 Mizuho
Uber has high probability of winning Prop. 22 appeal, says Mizuho
08/05/21 JPMorgan
Uber selloff brings 'compelling' opportunity, says JPMorgan
08/05/21 Jefferies
Uber driver supply investments should pay off in second half, says Jefferies
JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
VG Vonage
$14.11 /

+0.61 (+4.52%)

06/23/21 Citi
Vonage price target raised to $18 from $16 at Citi
06/21/21 Needham
Vonage initiated with a Hold at Needham
05/11/21 Craig-Hallum
8x8 downgraded to Hold at Craig-Hallum
03/05/21 Citi
Vonage price target raised to $16 from $15 at Citi
SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Jefferies
Virgin Galactic initiated with a Buy at Jefferies
08/12/21
Fly Intel: Top five analyst downgrades
08/12/21 Credit Suisse
Virgin Galactic reinstated at Neutral from Outperform at Credit Suisse
FNKO Funko
$19.92 /

+1.3 (+6.98%)

08/31/21
Fly Intel: Top five analyst upgrades
08/31/21 Jefferies
Jefferies upgrades Funko to Buy on confidence in 10%-plus growth
08/31/21 Jefferies
Funko upgraded to Buy from Hold at Jefferies
07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
APPS Digital Turbine
$58.53 /

+7.28 (+14.20%)

08/31/21 Macquarie
Digital Turbine initiated with Neutral, $60 target at Macquarie
08/31/21 Canaccord
Digital Turbine upgraded to Buy from Hold at Canaccord
MESO Mesoblast
$6.53 /

-0.765 (-10.49%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
TXT Textron
$72.68 /

+0.73 (+1.01%)

08/31/21 Cowen
Textron upgraded to Outperform on business jet momentum at Cowen
08/31/21 Cowen
Textron upgraded to Outperform from Market Perform at Cowen
08/02/21 Jefferies
Textron price target raised to $90 from $80 at Jefferies
AAPL Apple
$151.84 /

-1.27 (-0.83%)

09/01/21 BofA
Apple App Store risk would come from trusted alternative store, says BofA
09/01/21 Wolfe Research
Wolfe Research upgrades Apple to Peer Perform on U.S. promos, Huawei gains
09/01/21 Wolfe Research
Apple upgraded to Peer Perform from Underperform at Wolfe Research
09/01/21 Rosenblatt
Facebook downgraded to Neutral from Buy at Rosenblatt
TSM TSMC
$119.02 /

+0.01 (+0.01%)

08/02/21 Needham
Silicon Motion price target raised to $115 from $100 at Needham
07/19/21 Morgan Stanley
Texas Instruments price target raised to $185 from $176 at Morgan Stanley
07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
GOOG Alphabet
$2,910.98 /

+3.825 (+0.13%)

09/01/21 Canaccord
Anaplan results underscores its value proposition, says Canaccord
08/25/21 Bernstein
Google's payments to Apple might be $15B this year, says Bernstein
08/20/21 JPMorgan
Video application downloads trending lower, Google gaining, says JPMorgan
GOOGL Alphabet Class A
$2,893.93 /

+1.5 (+0.05%)

08/16/21 Jefferies
Sonos upgraded to Buy from Hold at Jefferies
AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

08/30/21 RBC Capital
Affirm price target raised to $124 from $87 at RBC Capital
08/30/21 Truist
Affirm price target raised to $120 from $82 at Truist
08/30/21 Morgan Stanley
Affirm price target raised to $120 from $73 at Morgan Stanley
08/30/21 Credit Suisse
Amazon deal could add 35%-40% to Affirm contribution profit, says Credit Suisse
WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

09/01/21 Morgan Stanley
Morgan Stanley says Wells already warned investors more penalties could come
09/01/21 JPMorgan
Wells Fargo shares not pricing in further regulatory issues, says JPMorgan
09/01/21 Deutsche Bank
Wells Fargo price target raised to $55 from $48 at Deutsche Bank
09/01/21 Piper Sandler
Bloomberg report 'bad news' for Wells Fargo, says Piper Sandler
ACIU AC Immune
$8.09 /

+1.075 (+15.32%)

08/31/21 H.C. Wainwright
Cognitive results for AC's semorinemab pushes Tau 'to the fore,' says Wainwright
08/31/21 SVB Leerink
AC Immune LAURIET data provides some initial validation, says SVB Leerink
03/24/21 H.C. Wainwright
AC Immune price target raised to $16 from $11 at H.C. Wainwright
SONN Sonnet BioTherapeutics
/

+

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
EGRX Eagle Pharmaceuticals
$53.53 /

+5.62 (+11.73%)

09/01/21 Piper Sandler
Eagle Pharmaceuticals price target raised to $51 from $48 at Piper Sandler
08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
04/06/21 RBC Capital
Eagle Pharmaceuticals transferred with an Outperform at RBC Capital
ENDP Endo
$2.28 /

-0.03 (-1.30%)

08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
GSAT Globalstar
$1.98 /

-0.36 (-15.38%)

08/30/21 William Blair
Apple may use Iridium connectivity 'down the road,' says William Blair
06/21/21 B. Riley
Globalstar initiated with a Buy at B. Riley
01/22/21 Morgan Stanley
Globalstar downgraded to Underweight after 266% rally at Morgan Stanley
01/22/21 Morgan Stanley
Globalstar downgraded to Underweight from Equal Weight at Morgan Stanley
IRDM Iridium
$44.54 /

-2.36 (-5.03%)

08/03/21 Morgan Stanley
Morgan Stanley starts Iridium at Overweight with $50 price target
08/03/21 Morgan Stanley
Iridium initiated with an Overweight at Morgan Stanley
07/26/21 Barclays
Iridium upgraded to Equal Weight from Underweight at Barclays
SOL ReneSola
$7.01 /

-0.09 (-1.27%)

06/09/21 Sidoti
ReneSola initiated with a Buy at Sidoti
03/29/21 H.C. Wainwright
ReneSola price target raised to $15 from $12 at H.C. Wainwright
03/09/21 Raymond James
ReneSola initiated with an Outperform at Raymond James
03/08/21 Raymond James
ReneSola initiated with an Outperform at Raymond James
AMWD American Woodmark
$70.50 /

-10.41 (-12.87%)

09/01/21 Loop Capital
American Woodmark price target lowered to $93 from $100 at Loop Capital
09/01/21 Baird
American Woodmark price target lowered to $74 from $90
06/22/21
Fly Intel: Top five analyst upgrades
06/22/21 Loop Capital
American Woodmark upgraded to Buy from Hold at Loop Capital
DBI Designer Brands
$14.52 /

-1.29 (-8.16%)

09/01/21 Deutsche Bank
Designer Brands price target raised to $19 from $18 at Deutsche Bank
03/17/21 Deutsche Bank
Designer Brands price target raised to $14 from $12 at Deutsche Bank
01/21/21 Deutsche Bank
Designer Brands price target raised to $12 from $7 at Deutsche Bank
01/08/21 CL King
Designer Brands named a top pick for 2021 at CL King
DXLG Destination XL
$5.99 /

+0.75 (+14.31%)

07/21/21 Craig-Hallum
Craig-Hallum bullish on Destination XL, initiates with a Buy
07/21/21 Craig-Hallum
Destination XL initiated with a Buy at Craig-Hallum
NTES NetEase
$97.47 /

+7.87 (+8.78%)

09/01/21 HSBC
NetEase price target lowered to $125 from $137 at HSBC
07/28/21 Citi
NetEase price target lowered to $132 from $148 at Citi
07/13/21 China Renaissance
NetEase assumed with a Buy at China Renaissance
05/19/21 CLSA
NetEase price target lowered to $134 from $159 at CLSA
CHS Chico's
$5.17 /

-0.685 (-11.71%)

06/09/21 B. Riley
Chico's price target raised to $5.25 from $2.50 at B. Riley
03/03/21 B. Riley
Chico's price target raised to $2.50 from $2 at B. Riley Securities
01/15/21 B. Riley
Chico's price target raised to $2 from $1.50 at B. Riley Securities
11/17/20 B. Riley
Chico's downgraded to Neutral on delayed recovery at B. Riley Securities
ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

VG Vonage
$14.11 /

+0.61 (+4.52%)

UBER Uber
$39.15 /

-0.4 (-1.01%)

TXT Textron
$72.68 /

+0.73 (+1.01%)

TSM TSMC
$119.02 /

+0.01 (+0.01%)

SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

SOL ReneSola
$7.01 /

-0.09 (-1.27%)

NTES NetEase
$97.47 /

+7.87 (+8.78%)

KSU Kansas City Southern
$280.74 /

-12.88 (-4.39%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

IRDM Iridium
$44.54 /

-2.36 (-5.03%)

GSAT Globalstar
$1.98 /

-0.36 (-15.38%)

GOOG Alphabet
$2,910.98 /

+3.825 (+0.13%)

FNKO Funko
$19.92 /

+1.3 (+6.98%)

ENDP Endo
$2.28 /

-0.03 (-1.30%)

EGRX Eagle Pharmaceuticals
$53.53 /

+5.62 (+11.73%)

DXLG Destination XL
$5.99 /

+0.75 (+14.31%)

DBI Designer Brands
$14.52 /

-1.29 (-8.16%)

CP Canadian Pacific
$68.75 /

-3.3 (-4.58%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

CHS Chico's
$5.17 /

-0.685 (-11.71%)

APPS Digital Turbine
$58.53 /

+7.28 (+14.20%)

AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

AMWD American Woodmark
$70.50 /

-10.41 (-12.87%)

ACIU AC Immune
$8.09 /

+1.075 (+15.32%)

AAPL Apple
$151.84 /

-1.27 (-0.83%)

  • 20
    Aug
  • 29
    Jul
  • 13
    Jan
  • 08
    Jan
ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

YNDX Yandex
$76.91 /

+3.78 (+5.17%)

WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

VG Vonage
$14.11 /

+0.61 (+4.52%)

UBER Uber
$39.15 /

-0.4 (-1.01%)

TSM TSMC
$119.02 /

+0.01 (+0.01%)

SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

NTES NetEase
$97.47 /

+7.87 (+8.78%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSAT Globalstar
$1.98 /

-0.36 (-15.38%)

GOOG Alphabet
$2,910.98 /

+3.825 (+0.13%)

FNKO Funko
$19.92 /

+1.3 (+6.98%)

ENDP Endo
$2.28 /

-0.03 (-1.30%)

EGRX Eagle Pharmaceuticals
$53.53 /

+5.62 (+11.73%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

AAPL Apple
$151.84 /

-1.27 (-0.83%)

ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

UBER Uber
$39.15 /

-0.4 (-1.01%)

TXT Textron
$72.68 /

+0.73 (+1.01%)

TSM TSMC
$119.02 /

+0.01 (+0.01%)

SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GOOG Alphabet
$2,910.98 /

+3.825 (+0.13%)

FNKO Funko
$19.92 /

+1.3 (+6.98%)

ENDP Endo
$2.28 /

-0.03 (-1.30%)

DBI Designer Brands
$14.52 /

-1.29 (-8.16%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

CHS Chico's
$5.17 /

-0.685 (-11.71%)

APPS Digital Turbine
$58.53 /

+7.28 (+14.20%)

AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

AAPL Apple
$151.84 /

-1.27 (-0.83%)

ZM Zoom Video
$289.48 /

-58.31 (-16.77%)

WFC Wells Fargo
$45.70 /

-2.71 (-5.60%)

VG Vonage
$14.11 /

+0.61 (+4.52%)

UBER Uber
$39.15 /

-0.4 (-1.01%)

TXT Textron
$72.68 /

+0.73 (+1.01%)

TSM TSMC
$119.02 /

+0.01 (+0.01%)

SPCE Virgin Galactic
$27.11 /

+2.24 (+9.01%)

SOL ReneSola
$7.01 /

-0.09 (-1.27%)

NTES NetEase
$97.47 /

+7.87 (+8.78%)

MESO Mesoblast
$6.53 /

-0.765 (-10.49%)

KSU Kansas City Southern
$280.74 /

-12.88 (-4.39%)

JNJ Johnson & Johnson
$173.11 /

-0.56 (-0.32%)

GSAT Globalstar
$1.98 /

-0.36 (-15.38%)

GOOGL Alphabet Class A
$2,893.93 /

+1.5 (+0.05%)

FNKO Funko
$19.92 /

+1.3 (+6.98%)

ENDP Endo
$2.28 /

-0.03 (-1.30%)

DXLG Destination XL
$5.99 /

+0.75 (+14.31%)

CP Canadian Pacific
$68.75 /

-3.3 (-4.58%)

CNI Canadian National
$117.66 /

+8.01 (+7.31%)

APPS Digital Turbine
$58.53 /

+7.28 (+14.20%)

AMZN Amazon.com
$3,471.36 /

+49.99 (+1.46%)

AAPL Apple
$151.84 /

-1.27 (-0.83%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:22
08/31/21
08/31
12:22
08/31/21
12:22
ZM

Zoom Video

$291.35 /

-56.44 (-16.23%)

, YNDX

Yandex

$76.15 /

+3.02 (+4.13%)

, UBER

Uber

$39.59 /

+0.04 (+0.10%)

, AAPL

Apple

$152.29 /

-0.82 (-0.54%)

, JNJ

Johnson & Johnson

$173.09 /

-0.58 (-0.33%)

, VG

Vonage

$14.41 /

+0.905 (+6.70%)

, CHS

Chico's

$4.98 /

-0.87 (-14.87%)

, GOOG

Alphabet

$2,916.50 /

+9.345 (+0.32%)

, GOOGL

Alphabet Class A

$2,898.47 /

+6.04 (+0.21%)

, TSM

TSMC

$119.23 /

+0.22 (+0.18%)

, PYPL

PayPal

$284.65 /

-3.79 (-1.31%)

, RYAAY

Ryanair

$107.82 /

-0.03 (-0.03%)

, ACIU

AC Immune

$9.28 /

+2.265 (+32.29%)

, SONN

Sonnet BioTherapeutics

/

+

, EGRX

Eagle Pharmaceuticals

$54.63 /

+6.72 (+14.03%)

, ENDP

Endo

$2.26 /

-0.05 (-2.17%)

, GSAT

Globalstar

$1.88 /

-0.46 (-19.66%)

, IRDM

Iridium

$42.97 /

-3.93 (-8.38%)

, SOL

ReneSola

$6.98 /

-0.12 (-1.69%)

, AMWD

American Woodmark

$68.83 /

-12.08 (-14.93%)

, DBI

Designer Brands

$14.62 /

-1.19 (-7.53%)

, DXLG

Destination XL

$5.24 /

-0.13 (-2.42%)

, NTES

NetEase

$94.44 /

+4.84 (+5.40%)

, RLGT

Radiant Logistics

$6.93 /

+0.31 (+4.68%)

, SPCE

Virgin Galactic

$27.29 /

+2.42 (+9.73%)

, FNKO

Funko

$20.11 /

+1.49 (+8.00%)

, APPS

Digital Turbine

$59.14 /

+7.89 (+15.40%)

, MESO

Mesoblast

$6.66 /

-0.63 (-8.64%)

, TXT

Textron

$72.71 /

+0.76 (+1.06%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

YNDX Yandex
$76.15 /

+3.02 (+4.13%)

VG Vonage
$14.41 /

+0.905 (+6.70%)

UBER Uber
$39.59 /

+0.04 (+0.10%)

TXT Textron
$72.71 /

+0.76 (+1.06%)

TSM TSMC
$119.23 /

+0.22 (+0.18%)

SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

SONN Sonnet BioTherapeutics
/

+

SOL ReneSola
$6.98 /

-0.12 (-1.69%)

RYAAY Ryanair
$107.82 /

-0.03 (-0.03%)

PYPL PayPal
$284.65 /

-3.79 (-1.31%)

NTES NetEase
$94.44 /

+4.84 (+5.40%)

MESO Mesoblast
$6.66 /

-0.63 (-8.64%)

JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

IRDM Iridium
$42.97 /

-3.93 (-8.38%)

GSAT Globalstar
$1.88 /

-0.46 (-19.66%)

GOOGL Alphabet Class A
$2,898.47 /

+6.04 (+0.21%)

GOOG Alphabet
$2,916.50 /

+9.345 (+0.32%)

FNKO Funko
$20.11 /

+1.49 (+8.00%)

ENDP Endo
$2.26 /

-0.05 (-2.17%)

EGRX Eagle Pharmaceuticals
$54.63 /

+6.72 (+14.03%)

DXLG Destination XL
$5.24 /

-0.13 (-2.42%)

DBI Designer Brands
$14.62 /

-1.19 (-7.53%)

CHS Chico's
$4.98 /

-0.87 (-14.87%)

APPS Digital Turbine
$59.14 /

+7.89 (+15.40%)

AMWD American Woodmark
$68.83 /

-12.08 (-14.93%)

ACIU AC Immune
$9.28 /

+2.265 (+32.29%)

AAPL Apple
$152.29 /

-0.82 (-0.54%)

ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

08/31/21 KeyBanc
Zoom Video price target lowered to $398 from $428 at KeyBanc
08/31/21 Stifel
Zoom Video price target lowered to $350 from $450 at Stifel
08/31/21 Deutsche Bank
Zoom Video price target lowered to $350 from $375 at Deutsche Bank
08/31/21 BofA
Zoom Video price target lowered to $385 from $480 at BofA
YNDX Yandex
$76.15 /

+3.02 (+4.13%)

04/14/21 VTB Capital
Yandex pullback on FAS probe a buying opportunity, says VTB Capital
04/14/21 VTB Capital
Yandex named long idea after 'excessive' selloff at VTB Capital
04/06/21 New Street
New Street starts Yandex at Buy with focus on food, grocery
04/06/21 New Street
Yandex initiated with a Buy at New Street
UBER Uber
$39.59 /

+0.04 (+0.10%)

08/23/21 JPMorgan
Court ruling brings near-term uncertainty to Uber and Lyft, says JPMorgan
08/23/21 Mizuho
Uber has high probability of winning Prop. 22 appeal, says Mizuho
08/05/21 JPMorgan
Uber selloff brings 'compelling' opportunity, says JPMorgan
08/05/21 Jefferies
Uber driver supply investments should pay off in second half, says Jefferies
AAPL Apple
$152.29 /

-0.82 (-0.54%)

08/31/21 Bernstein
Apple car likely all-electric, not expected before 2025, says Bernstein
08/30/21 William Blair
Apple may use Iridium connectivity 'down the road,' says William Blair
08/27/21 BofA
Apple could be negatively affected from developer settlement, says BofA
08/25/21 Evercore ISI
Apple's advertising business could grow to $20B in FY25, says Evercore ISI
JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
VG Vonage
$14.41 /

+0.905 (+6.70%)

06/23/21 Citi
Vonage price target raised to $18 from $16 at Citi
06/21/21 Needham
Vonage initiated with a Hold at Needham
05/11/21 Craig-Hallum
8x8 downgraded to Hold at Craig-Hallum
03/05/21 Citi
Vonage price target raised to $16 from $15 at Citi
CHS Chico's
$4.98 /

-0.87 (-14.87%)

06/09/21 B. Riley
Chico's price target raised to $5.25 from $2.50 at B. Riley
03/03/21 B. Riley
Chico's price target raised to $2.50 from $2 at B. Riley Securities
01/15/21 B. Riley
Chico's price target raised to $2 from $1.50 at B. Riley Securities
11/17/20 B. Riley
Chico's downgraded to Neutral on delayed recovery at B. Riley Securities
GOOG Alphabet
$2,916.50 /

+9.345 (+0.32%)

08/25/21 Bernstein
Google's payments to Apple might be $15B this year, says Bernstein
08/20/21 JPMorgan
Video application downloads trending lower, Google gaining, says JPMorgan
08/16/21 Jefferies
Sonos upgraded to Buy from Hold at Jefferies
08/03/21 Bernstein
Google using own chips 'financial immaterial' for Qualcomm, says Bernstein
GOOGL Alphabet Class A
$2,898.47 /

+6.04 (+0.21%)

08/10/21 DA Davidson
Trade Desk price target raised to $95 from $65 at DA Davidson
TSM TSMC
$119.23 /

+0.22 (+0.18%)

08/02/21 Needham
Silicon Motion price target raised to $115 from $100 at Needham
07/19/21 Morgan Stanley
Texas Instruments price target raised to $185 from $176 at Morgan Stanley
07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
PYPL PayPal
$284.65 /

-3.79 (-1.31%)

08/31/21 Wolfe Research
PayPal report of stock trading platform not new news, says Wolfe Research
07/29/21 KeyBanc
PayPal should be bought on any weakness, says KeyBanc
07/29/21 Morgan Stanley
Morgan Stanley bumps up PayPal price target to $340, sees 'positive indicators'
07/29/21 Jefferies
Jefferies says PayPal 'still strong under the hood' despite transitory headwinds
RYAAY Ryanair
$107.82 /

-0.03 (-0.03%)

07/27/21 Redburn
Ryanair upgraded to Buy from Neutral at Redburn
07/12/21 Morgan Stanley
Ryanair price target raised to EUR 20 from EUR 17 at Morgan Stanley
07/12/21 JPMorgan
Ryanair price target raised to EUR 16.40 from EUR 15.80 at JPMorgan
07/12/21 Evercore ISI
Evercore upgrades 'high quality laggard' Ryanair to Outperform
ACIU AC Immune
$9.28 /

+2.265 (+32.29%)

08/31/21 H.C. Wainwright
Cognitive results for AC's semorinemab pushes Tau 'to the fore,' says Wainwright
08/31/21 SVB Leerink
AC Immune LAURIET data provides some initial validation, says SVB Leerink
03/24/21 H.C. Wainwright
AC Immune price target raised to $16 from $11 at H.C. Wainwright
SONN Sonnet BioTherapeutics
/

+

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
EGRX Eagle Pharmaceuticals
$54.63 /

+6.72 (+14.03%)

08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
04/06/21 RBC Capital
Eagle Pharmaceuticals transferred with an Outperform at RBC Capital
ENDP Endo
$2.26 /

-0.05 (-2.17%)

07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/17/21 Citi
Endo price target raised to $11 from $10 at Citi
GSAT Globalstar
$1.88 /

-0.46 (-19.66%)

06/21/21 B. Riley
Globalstar initiated with a Buy at B. Riley
01/22/21 Morgan Stanley
Globalstar downgraded to Underweight after 266% rally at Morgan Stanley
01/22/21 Morgan Stanley
Globalstar downgraded to Underweight from Equal Weight at Morgan Stanley
IRDM Iridium
$42.97 /

-3.93 (-8.38%)

08/03/21 Morgan Stanley
Morgan Stanley starts Iridium at Overweight with $50 price target
08/03/21 Morgan Stanley
Iridium initiated with an Overweight at Morgan Stanley
07/26/21 Barclays
Iridium upgraded to Equal Weight from Underweight at Barclays
SOL ReneSola
$6.98 /

-0.12 (-1.69%)

06/09/21 Sidoti
ReneSola initiated with a Buy at Sidoti
03/29/21 H.C. Wainwright
ReneSola price target raised to $15 from $12 at H.C. Wainwright
03/09/21 Raymond James
ReneSola initiated with an Outperform at Raymond James
03/08/21 Raymond James
ReneSola initiated with an Outperform at Raymond James
AMWD American Woodmark
$68.83 /

-12.08 (-14.93%)

06/22/21
Fly Intel: Top five analyst upgrades
06/22/21 Loop Capital
American Woodmark upgraded to Buy from Hold at Loop Capital
06/22/21 Loop Capital
American Woodmark upgraded to Buy from Hold at Loop Capital
03/17/21 Wolfe Research
American Woodmark initiated with a Peer Perform at Wolfe Research
DBI Designer Brands
$14.62 /

-1.19 (-7.53%)

03/17/21 Deutsche Bank
Designer Brands price target raised to $14 from $12 at Deutsche Bank
01/21/21 Deutsche Bank
Designer Brands price target raised to $12 from $7 at Deutsche Bank
01/08/21 CL King
Designer Brands named a top pick for 2021 at CL King
11/09/20 UBS
Designer Brands initiated with a Neutral at UBS
DXLG Destination XL
$5.24 /

-0.13 (-2.42%)

07/21/21 Craig-Hallum
Craig-Hallum bullish on Destination XL, initiates with a Buy
07/21/21 Craig-Hallum
Destination XL initiated with a Buy at Craig-Hallum
NTES NetEase
$94.44 /

+4.84 (+5.40%)

07/28/21 Citi
NetEase price target lowered to $132 from $148 at Citi
07/13/21 China Renaissance
NetEase assumed with a Buy at China Renaissance
05/19/21 CLSA
NetEase price target lowered to $134 from $159 at CLSA
05/19/21 Macquarie
NetEase price target lowered to $118 from $124 at Macquarie
RLGT Radiant Logistics
$6.93 /

+0.31 (+4.68%)

03/26/21 Vertical Research
Radiant Logistics initiated with a Buy at Vertical Research
SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Jefferies
Virgin Galactic initiated with a Buy at Jefferies
08/12/21
Fly Intel: Top five analyst downgrades
08/12/21 Credit Suisse
Virgin Galactic reinstated at Neutral from Outperform at Credit Suisse
FNKO Funko
$20.11 /

+1.49 (+8.00%)

08/31/21
Fly Intel: Top five analyst upgrades
08/31/21 Jefferies
Jefferies upgrades Funko to Buy on confidence in 10%-plus growth
08/31/21 Jefferies
Funko upgraded to Buy from Hold at Jefferies
07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
APPS Digital Turbine
$59.14 /

+7.89 (+15.40%)

08/31/21 Macquarie
Digital Turbine initiated with Neutral, $60 target at Macquarie
08/31/21 Canaccord
Digital Turbine upgraded to Buy from Hold at Canaccord
MESO Mesoblast
$6.66 /

-0.63 (-8.64%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
TXT Textron
$72.71 /

+0.76 (+1.06%)

08/31/21 Cowen
Textron upgraded to Outperform on business jet momentum at Cowen
08/31/21 Cowen
Textron upgraded to Outperform from Market Perform at Cowen
08/02/21 Jefferies
Textron price target raised to $90 from $80 at Jefferies
ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

VG Vonage
$14.41 /

+0.905 (+6.70%)

UBER Uber
$39.59 /

+0.04 (+0.10%)

TXT Textron
$72.71 /

+0.76 (+1.06%)

TSM TSMC
$119.23 /

+0.22 (+0.18%)

SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

SOL ReneSola
$6.98 /

-0.12 (-1.69%)

RLGT Radiant Logistics
$6.93 /

+0.31 (+4.68%)

PYPL PayPal
$284.65 /

-3.79 (-1.31%)

NTES NetEase
$94.44 /

+4.84 (+5.40%)

JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

IRDM Iridium
$42.97 /

-3.93 (-8.38%)

GSAT Globalstar
$1.88 /

-0.46 (-19.66%)

GOOG Alphabet
$2,916.50 /

+9.345 (+0.32%)

FNKO Funko
$20.11 /

+1.49 (+8.00%)

ENDP Endo
$2.26 /

-0.05 (-2.17%)

EGRX Eagle Pharmaceuticals
$54.63 /

+6.72 (+14.03%)

DXLG Destination XL
$5.24 /

-0.13 (-2.42%)

DBI Designer Brands
$14.62 /

-1.19 (-7.53%)

CHS Chico's
$4.98 /

-0.87 (-14.87%)

APPS Digital Turbine
$59.14 /

+7.89 (+15.40%)

AMWD American Woodmark
$68.83 /

-12.08 (-14.93%)

ACIU AC Immune
$9.28 /

+2.265 (+32.29%)

AAPL Apple
$152.29 /

-0.82 (-0.54%)

  • 20
    Aug
  • 29
    Jul
  • 13
    Jan
  • 08
    Jan
ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

YNDX Yandex
$76.15 /

+3.02 (+4.13%)

VG Vonage
$14.41 /

+0.905 (+6.70%)

UBER Uber
$39.59 /

+0.04 (+0.10%)

TSM TSMC
$119.23 /

+0.22 (+0.18%)

SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

RYAAY Ryanair
$107.82 /

-0.03 (-0.03%)

PYPL PayPal
$284.65 /

-3.79 (-1.31%)

NTES NetEase
$94.44 /

+4.84 (+5.40%)

JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

GSAT Globalstar
$1.88 /

-0.46 (-19.66%)

GOOG Alphabet
$2,916.50 /

+9.345 (+0.32%)

FNKO Funko
$20.11 /

+1.49 (+8.00%)

ENDP Endo
$2.26 /

-0.05 (-2.17%)

EGRX Eagle Pharmaceuticals
$54.63 /

+6.72 (+14.03%)

AAPL Apple
$152.29 /

-0.82 (-0.54%)

ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

UBER Uber
$39.59 /

+0.04 (+0.10%)

TXT Textron
$72.71 /

+0.76 (+1.06%)

TSM TSMC
$119.23 /

+0.22 (+0.18%)

SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

SOL ReneSola
$6.98 /

-0.12 (-1.69%)

PYPL PayPal
$284.65 /

-3.79 (-1.31%)

NTES NetEase
$94.44 /

+4.84 (+5.40%)

JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

GOOG Alphabet
$2,916.50 /

+9.345 (+0.32%)

FNKO Funko
$20.11 /

+1.49 (+8.00%)

ENDP Endo
$2.26 /

-0.05 (-2.17%)

DBI Designer Brands
$14.62 /

-1.19 (-7.53%)

CHS Chico's
$4.98 /

-0.87 (-14.87%)

APPS Digital Turbine
$59.14 /

+7.89 (+15.40%)

AAPL Apple
$152.29 /

-0.82 (-0.54%)

ZM Zoom Video
$291.35 /

-56.44 (-16.23%)

VG Vonage
$14.41 /

+0.905 (+6.70%)

UBER Uber
$39.59 /

+0.04 (+0.10%)

TXT Textron
$72.71 /

+0.76 (+1.06%)

TSM TSMC
$119.23 /

+0.22 (+0.18%)

SPCE Virgin Galactic
$27.29 /

+2.42 (+9.73%)

SOL ReneSola
$6.98 /

-0.12 (-1.69%)

PYPL PayPal
$284.65 /

-3.79 (-1.31%)

NTES NetEase
$94.44 /

+4.84 (+5.40%)

MESO Mesoblast
$6.66 /

-0.63 (-8.64%)

JNJ Johnson & Johnson
$173.09 /

-0.58 (-0.33%)

GSAT Globalstar
$1.88 /

-0.46 (-19.66%)

GOOGL Alphabet Class A
$2,898.47 /

+6.04 (+0.21%)

FNKO Funko
$20.11 /

+1.49 (+8.00%)

ENDP Endo
$2.26 /

-0.05 (-2.17%)

DXLG Destination XL
$5.24 /

-0.13 (-2.42%)

APPS Digital Turbine
$59.14 /

+7.89 (+15.40%)

AAPL Apple
$152.29 /

-0.82 (-0.54%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:52
08/31/21
08/31
09:52
08/31/21
09:52
ZY

Zymergen

$12.99 /

-0.02 (-0.15%)

, DSPG

DSP Group

$21.92 /

-0.06 (-0.27%)

, MESO

Mesoblast

$6.30 /

-0.99 (-13.58%)

, HEPS

Hepsiburada

$9.49 /

-0.27 (-2.77%)

, GOL

Gol Linhas

$7.80 /

+0.035 (+0.45%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Zymergen (ZY) downgraded to Neutral from Buy at UBS with analyst John Sourbeer saying the company's opportunities are now "further out on the horizon" due to headwinds with its first product Hyaline and scale manufacturing "remains a risk." 2. DSP Group (DSPG) downgraded to Hold from Buy at Needham, and Lake Street and downgraded to Market Perform from Outperform at Cowen. 3. Mesoblast (MESO) downgraded to Hold from Buy at Jefferies with analyst David Stanton saying while his view on the timelines for approval for Mesoblast's major opportunities are unchanged, Stanton has removed the adult acute steroid-refractory graft versus host disease opportunity from his forecasts to be conservative ahead of the company's upcoming face-to-face meetings with the review team at the U.S. Office of Tissue and Advanced Therapies regarding remestemcel in SR-aGvHD. 4. Hepsiburada (HEPS) downgraded to Neutral from Buy at BofA with analyst Cesar Tiron saying while he views the company's growth profile as attractive, Q2 results and his recent call with its CFO have "highlighted a cloudier operating outlook" as Hepsiburada needs to step up investments to meet its GMV target for FY21. 5. Gol Linhas (GOL) downgraded to Underperform from Neutral at Credit Suisse with analyst Alejandro Zamacona Urquiza saying Gol may be the main beneficiary from the potential traffic recovery in the business segment in Brazil, given its "strong" network position in Sao Paulo, Rio de Janeiro and Brasilia. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
ZY Zymergen
$12.99 /

-0.02 (-0.15%)

MESO Mesoblast
$6.30 /

-0.99 (-13.58%)

GOL Gol Linhas
$7.80 /

+0.035 (+0.45%)

DSPG DSP Group
$21.92 /

-0.06 (-0.27%)

ZY Zymergen
$12.99 /

-0.02 (-0.15%)

08/31/21 UBS
Zymergen downgraded to Neutral from Buy at UBS
08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Cowen
Cowen downgrades Zymergen on changes pending further information
08/04/21 BofA
BofA double downgrades Zymergen to sell on 'worrying' execution issues
DSPG DSP Group
$21.92 /

-0.06 (-0.27%)

08/31/21 Needham
DSP Group downgraded to Hold from Buy at Needham
08/31/21 Cowen
DSP Group downgraded to Market Perform from Outperform at Cowen
08/31/21 Lake Street
DSP Group downgraded to Hold from Buy at Lake Street
08/30/21 Colliers
DSP Group downgraded to Neutral from Buy at Colliers
MESO Mesoblast
$6.30 /

-0.99 (-13.58%)

08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
02/11/21 Chardan
Mesoblast will need additional studies after Phase III miss, says Chardan
HEPS Hepsiburada
$9.49 /

-0.27 (-2.77%)

08/31/21 BofA
Hepsiburada downgraded to Neutral from Buy at BofA
08/04/21
Fly Intel: Top five analyst initiations
08/04/21 HSBC
Hepsiburada initiated with a Buy at HSBC
07/27/21
Fly Intel: Top five analyst initiations
GOL Gol Linhas
$7.80 /

+0.035 (+0.45%)

08/31/21 Credit Suisse
Gol Linhas assumed with Underperform from Neutral at Credit Suisse
06/14/21 HSBC
Gol Linhas price target raised to R$26 from R$25 at HSBC
05/05/21 HSBC
Gol Linhas downgraded to Hold from Buy at HSBC
04/11/21 Goldman Sachs
Gol Linhas price target lowered to $9.85 from $11.05 at Goldman Sachs
ZY Zymergen
$12.99 /

-0.02 (-0.15%)

GOL Gol Linhas
$7.80 /

+0.035 (+0.45%)

DSPG DSP Group
$21.92 /

-0.06 (-0.27%)

  • 01
    Jul
  • 22
    Apr
ZY Zymergen
$12.99 /

-0.02 (-0.15%)

ZY Zymergen
$12.99 /

-0.02 (-0.15%)

HEPS Hepsiburada
$9.49 /

-0.27 (-2.77%)

GOL Gol Linhas
$7.80 /

+0.035 (+0.45%)

DSPG DSP Group
$21.92 /

-0.06 (-0.27%)

ZY Zymergen
$12.99 /

-0.02 (-0.15%)

MESO Mesoblast
$6.30 /

-0.99 (-13.58%)

Hot Stocks
Mesoblast told by FDA additional study required for remestemcel-L » 07:55
08/31/21
08/31
07:55
08/31/21
07:55
MESO

Mesoblast

$7.29 /

-0.19 (-2.54%)

Mesoblast announced last…

Mesoblast announced last night that it met with the Food and Drug Administration in regard to potential emergency use authorization for remestemcel-L in the treatment of ventilator-dependent patients with moderate or severe acute respiratory distress syndrome due to Covid-19. The FDA advised Mesoblast that an additional clinical study in COVID ARDS would be required which, if statistically positive, could provide a dataset in conjunction with the recently completed 222 patient clinical study that might be sufficient to support an EUA. The FDA indicated that potency assays must be established and agreed prior to commencement of the proposed Phase 3 clinical trial, the company added. The agency "indicated that the potency assays currently in development appeared to be reasonable based on in vitro results provided in the briefing document, the in vitro activity of the product appears to be relatively well established, though the relationship between in vitro activity and the product's actual mechanism of action remains theoretical," according to Mesoblast. The company intends to meet with FDA's Office of Tissue and Advanced Therapies in Q4 to address potency assays for remestemcel-L. Shares of Mesoblast are down 14% to $6.32 in premarket trading.

ShowHide Related Items >><<
MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

08/31/21 Chardan
Mesoblast price target lowered to $6.50 from $7.50 at Chardan
08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
02/11/21 Chardan
Mesoblast will need additional studies after Phase III miss, says Chardan
MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

Recommendations
Mesoblast price target lowered to $6.50 from $7.50 at Chardan » 07:52
08/31/21
08/31
07:52
08/31/21
07:52
MESO

Mesoblast

$7.29 /

-0.19 (-2.54%)

Chardan analyst Keay…

Chardan analyst Keay Nakae lowered the firm's price target on Mesoblast to $6.50 from $7.50 and keeps a Sell rating on the shares. The key takeaway from the Q4 results was the company revealing that it has been informed by the FDA that the agency will not consider granting emergency use authorization for remestemcel-L as a treatment of Covid-19 acute respiratory distress syndrome based on the data from the recent Phase III study, Nakae tells investors in a research note. Despite the recent surge in Covid-19 infections, the analyst believes the window of opportunity for remestemcel-L as a treatment for Covid-19 ARDS in the U.S. is "very narrow." Nakae sees an unfavorable risk/reward at the current stock price.

ShowHide Related Items >><<
MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

08/31/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
04/07/21 Maxim
Mesoblast upgraded to Buy from Hold at Maxim
02/11/21 Chardan
Mesoblast will need additional studies after Phase III miss, says Chardan
01/19/21 Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
MESO Mesoblast
$7.29 /

-0.19 (-2.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.